Drug Therapy

1. Pramipexole: in restless legs syndrome.

Author
McCormack PL; Siddiqui MA;
Institution
Wolters Kluwer Health | Adis, Auckland, New Zealand, an editorial office of Wolters Kluwer Health, Conshohocken, Pennsylvania, USA.
Journal
CNS Drugs. 2007;21(5):429-37.
Abstract URL
Click here to view abstract

2. Augmentation of restless legs syndrome with long-term tramadol treatment.

Author
Vetrugno R; La Morgia C; D'Angelo R; Loi D; Provini F; Plazzi G; Montagna P;
Institution
Department of Neurological Sciences, University of Bologna, Bologna, Italy. vetrugno@neuro.unibo.it
Journal
Mov Disord. 2007 Feb 15;22(3):424-7.
Abstract URL
Click here to view abstract

3. Pregabalin in restless legs syndrome with and without neuropathic pain.

Author
Sommer M; Bachmann CG; Liebetanz KM; Schindehutte J; Tings T; Paulus W;
Institution
Department of Clinical Neurophysiology, University of Goettingen, Goettingen, Germany. msommer@med.uni-goettingen.de
Journal
Acta Neurol Scand. 2007 May;115(5):347-50.
Abstract URL
Click here to view abstract

4. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.

Author
Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L;
Institution
Sleep Disorders Center, Department of Neurology, Scientific Institute and University Ospedale San Raffaele, Vita-Salute University, Milan, Italy.
Journal
Sleep Med. 2007 May 17;.
Abstract URL
Click here to view abstract

5. Methadone for refractory restless legs syndrome.

Author
Ondo, William G;
Institution
Baylor College of Medicine, Houston Texas 77030-2744, USA. wondo@bcm.tmc.edu
Journal
Mov Disord. 2005 Mar;20(3):345-8.
Abstract URL
Click here to view abstract

6. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome.

Author
Earley CJ; Heckler D; Allen RP;
Institution
Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA. cearley@jhmi.edu
Journal
Sleep Med. 2005 Jul;6(4):301-5. Epub 2005 Apr 1.
Abstract URL
Click here to view abstract

7. Restless legs syndrome: Diagnostic assessment and the advantages and risks of dopaminergic treatment.

Author
Hogl B; Paulus W; Clarenbach P; Trenkwalder C;
Institution
Dept. of Neurology, Medical University, 6020, Innsbruck, Austria, birgit.ho@uibk.ac.at.
Journal
J Neurol. 2006 Aug;253 Suppl 4:iv22-iv28.
Abstract URL
Click here to view abstract

8. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.

Author
Giorgi L; Ritchie SY; Kirsch JM;
Institution
GlaxoSmithKline, Greenford, UK. luigi.2.giorgi@gsk.com
Journal
Curr Med Res Opin. 2006 Oct;22(10):1867-77.
Abstract URL
Click here to view abstract

9. Medication tolerance and augmentation in restless legs syndrome: the need for drug class rotation.

Author
Kurlan R; Richard IH; Deeley C; Kurlan R; Richard IH; Deeley C;
Institution
Movement Disorders Unit, Department of Neurology, University of Rochester School of Medicine, Rochester, NY, USA.
Journal
J Gen Intern Med. 2006 Dec;21(12):C1-4.
Abstract URL
Click here to view abstract

10. Long-term treatment with pramipexole in restless legs syndrome.

Author
Montplaisir J; Fantini ML; Desautels A; Michaud M; Petit D; Filipini D;
Institution
Centre d'etude du sommeil et des rythmes biologiques, Hopital du Sacre-Coeur de Montreal, Universite de Montreal, QC, Canada. jy.montplaisir@umontreal.ca
Journal
Eur J Neurol. 2006 Dec;13(12):1306-11.
Abstract URL
Click here to view abstract

11. Ropinirole: new indication. Restless legs: disproportionate adverse effects.

Author
Institution
Journal
Prescrire Int. 2006 Oct;15(85):173-6.
Abstract URL
Click here to view abstract

12. Ropinirole (Requip) for restless legs syndrome.

Author
Institution
Journal
Med Lett Drugs Ther 2005 Aug 1;47(1214):62-4.

13. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome.

Author
Konofal, Eric; Arnulf, Isabelle; Lecendreux, Michel; Mouren, Marie-Christine;
Institution
Service de Psychopathologie de l'Enfant et de l'Adolescent, Hopital Robert Debre, Paris, France.
Journal
Pediatr Neurol 2005 May;32(5):350-1.
Abstract URL
Click here to view abstract

14. Role of medications in the etiology and treatment of restless leg syndrome.

Author
Neafsey, Patricia J;
Institution
Journal
Home Healthc Nurse 2005 Apr;23(4):207-9.

15. The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study.

Author
von Spiczak, Sarah; Whone, Alan L; Hammers, Alexander; Asselin, Marie-Claude; Turkheimer, Federico; Tings, Tobias; Happe, Svenja; Paulus, Walter; Trenkwalder, Claudia; Brooks, David J;
Institution
Division of Neuroscience and MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, London, UK. sarah.v.s@gmx.de
Journal
Brain 2005 Apr;128(Pt 4):906-17. Epub 2005 Feb 23.
Abstract URL
Click here to view abstract